Long-term management of Alport syndrome in pediatric patients

Clifford E Kashtan Department of Pediatrics, Division of Nephrology, University of Minnesota Medical School, Minneapolis, MN, USA Abstract: Alport syndrome, an important inherited cause of end-stage renal disease, has long been considered an untreatable disorder. That view is changing as a result of...

Full description

Saved in:
Bibliographic Details
Main Author: Kashtan CE (Author)
Format: Book
Published: Dove Medical Press, 2013-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c5adb0a4c9064f56ac4d90b54b91c0b0
042 |a dc 
100 1 0 |a Kashtan CE  |e author 
245 0 0 |a Long-term management of Alport syndrome in pediatric patients 
260 |b Dove Medical Press,   |c 2013-06-01T00:00:00Z. 
500 |a 1179-9927 
520 |a Clifford E Kashtan Department of Pediatrics, Division of Nephrology, University of Minnesota Medical School, Minneapolis, MN, USA Abstract: Alport syndrome, an important inherited cause of end-stage renal disease, has long been considered an untreatable disorder. That view is changing as a result of treatment studies in experimental animals and human populations. This review describes current management of Alport kidney disease, which is based on early diagnosis and institution of therapy with antagonists of the renin-angiotensin-aldosterone system. Keywords: Alport syndrome, glomerular basement membrane, type IV collagen, familial hematuria 
546 |a EN 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Pediatric Health, Medicine and Therapeutics, Vol 2013, Iss default, Pp 41-45 (2013) 
787 0 |n http://www.dovepress.com/long-term-management-of-alport-syndrome-in-pediatric-patients-a13233 
787 0 |n https://doaj.org/toc/1179-9927 
856 4 1 |u https://doaj.org/article/c5adb0a4c9064f56ac4d90b54b91c0b0  |z Connect to this object online.